Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy Intervention: Other: 12 months of guideline-directed heart failure therapy Sponsors: Imperial College London; Royal Brompton & Harefield NHS Foundation Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials